Oncobiomix Adopts AI-Based Disease Insights Platform for Prostate Cancer Test
Oncobiomix says it will use Limmi’s Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Read MorePosted by Andy Lundin | Feb 20, 2024 | Prostate |
Oncobiomix says it will use Limmi’s Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Read MorePosted by Andy Lundin | Feb 16, 2024 | Cancer |
By analyzing fragments of cfDNA in a simple blood draw, the Galleri test can screen for many deadly cancers.
Read MorePosted by Chris Wolski | Feb 9, 2024 | Cancer |
While being treated for an enlarged prostate, Britain’s King Charles III was diagnosed with an undisclosed form of cancer.
Read MorePosted by Andy Lundin | Feb 2, 2024 | Cancer, Company News |
The funding aims to propel ArteraAI forward in its mission to personalize cancer therapy through AI-enabled predictive and prognostic tests.
Read MorePosted by Chris Wolski | Feb 1, 2024 | Emerging & Zoonotic Diseases |
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read More